Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 19 Nov 2025

Comparative effectiveness and pharmacological fingerprints of indobufen versus rivaroxaban in patients with chronic kidney disease: a single-center, real-world study

in Renal Pharmacology

Lijun Zhang
Mingbo Liu
Tingting Huang
He Zhang
Chuanfu Huang
Zhenbin Pan
Zhao Chen
Jun Ning
Jiameng Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1694163

231 views

Original Research

Published on 18 Nov 2025

In vivo pharmacokinetic evaluation of molnupiravir in patients with severe chronic kidney disease

in Renal Pharmacology

Yuanyuan Wang
Qiong Chen
Xuan Liu
Ling Zhang
Ming Chen
Shuowen Wang
Man Yang
Guorong Fan
Qiuling Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1696197

259 views

Review

Published on 18 Nov 2025

Comparison of short-term and long-term renal function effects of vasopressin and norepinephrine in patients with septic shock: a systematic review and meta-analysis

in Renal Pharmacology

Hongyu Wang
Xilin Liu
Hong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1669636

315 views

Systematic Review

Published on 14 Nov 2025

Effect of intravitreal VEGF inhibitors on renal-related adverse events in patients with diabetes mellitus: systematic review and meta-analysis

in Renal Pharmacology

Yu Zheng
Fan Zhang
Xueling Li
Xianwen Zhang
Yifei Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1691597

363 views

Review

Published on 13 Nov 2025

Immunomodulatory roles of quercetin in diabetic nephropathy: targeting inflammation, oxidative stress, and ferroptosis

in Renal Pharmacology

YaFeng Zheng
XiaoNa Ye
XingJun Han
Wei Geng
Longsheng Zhao
Dandan Meng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1687677

579 views

Correction

Published on 12 Nov 2025

Correction: Renoprotective effects of GHRH agonist MR409 is associated with reduced oxidative stress and ferroptosis in diabetic mice

in Renal Pharmacology

Yueyang Liu
Rong Fu
Qi Tang
Yaoxia Zhang
Ruiping Cai
Limin Liu
Hui Jia
Junjia Gao
Ming-Sheng Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1737333

188 views

Original Research

Published on 12 Nov 2025

Procyanidin displayed a synergistic effect with roxadustat on renal anemia in mice

in Renal Pharmacology

Mingyang Cui
Zhe Wang
Jiaxin Shi
Wenbin Wu
Jin Tao
Yujing Han
Zihui Yang
Junjie Luo
Yongting Luo
Peng An

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1678846

673 views

Review

Published on 06 Nov 2025

siRNA-mediated therapeutic approaches improve acute kidney injury and limit its worsening

in Renal Pharmacology

Xijian Wang
Xinzhong Huang
Bin Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1697460

835 views

Original Research

Published on 06 Nov 2025

Development of a venous thromboembolism risk prediction model for patients with primary membranous nephropathy based on machine learning

in Renal Pharmacology

Lian Li
Liuyun Wu
Yin Wang
Hulin Wang
Xingyue Zheng
Lizhu Han
Qinan Yin
Xingwei Wu
Yuan Bian

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1683708

675 views

Original Research

Published on 31 Oct 2025

Clinical efficacy and safety of tripterygium wilfordii glycosides in the treatment of idiopathic membranous nephropathy: a systematic review and meta-analysis

in Renal Pharmacology

Ying Liu
Keda Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1652789

611 views

Original Research

Published on 31 Oct 2025

Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway

in Renal Pharmacology

Weili Liao
Rui Fan
Yuman Du
Hairong Wang
Yong Yang
Yuan Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1648623

1,423 views

Review

Accepted on 27 Oct 2025

Licorice in Nephropathy Treatment: Phytochemical Compositions and Pharmacological Mechanisms

in Renal Pharmacology

Ya-long Feng
Le Shui
Yinxuan Jiang
Yanni Wang
Lin Chen
Hua Chen
Wen-Bo Wang

Frontiers in Pharmacology

263 views

Correction

Published on 27 Oct 2025

Correction: Astragaloside IV alleviates tacrolimus-induced chronic nephrotoxicity via p62-Keap1-Nrf2 pathway

in Renal Pharmacology

Ping Gao
Xiaoyi Du
Lili Liu
Hua Xu
Maochang Liu
Xinlei Guan
Chengliang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1710116

445 views

Original Research

Published on 20 Oct 2025

Hemodialysis-induced renal perfusion decline: unraveling the pathophysiological mechanisms linking intradialytic circulatory stress to residual renal function loss

in Renal Pharmacology

Dayang Xie
Jiaming Tan
Qingtao Zhang
Qian Yu
Yiqin Wang
Yujin Wang
Li Gao
Liyuan Yan
Jianhui Zhou
Nan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1648608

853 views

General Commentary

Published on 17 Oct 2025

Commentary: Efficacy and safety of HSK21542 for pruritus management in hemodialysis patients: a multicenter, randomized, double-blind, placebo-controlled trial

in Renal Pharmacology

Steven Fishbane

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1689698

989 views

Correction

Published on 10 Oct 2025

Correction: Post-translational modifications in sepsis-induced acute kidney injury: mechanisms and perspectives

in Renal Pharmacology

Lin Song
Wei Jiang
Ke Liu
Jing Wang
Weilei Gong
Jiangquan Yu
Ruiqiang Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1710281

981 views